Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01118858 · ClinicalTrials.gov registry record
Biomarkers of CYP2D6 and CYP3A4 Variability in Pediatrics
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 205
- Enrollment target
NCT01118858 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 205 participants.
The verdict
NCT01118858 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 205 participants
- Enrollment target
Study Summary
Cytochrome P450 2D6 (CYP2D6) is an important enzyme in the body for breaking down many medications that are commonly used in children of various ages. The purpose of this proposal is to investigate the relative roles of development and genetic variation in CYP2D6 activity in school-aged children and adolescents with attention deficit and hyperactivity disorder and health controls using the over-the-counter cough suppressant, dextromethorphan or "DM", a standard probe for determining CYP2D6 phenotype. Embedded in the study design are sub-studies to search for by-products of normal body metabolism that reflect differences in enzyme activity, and a pharmacokinetic study to assess the consequences of CYP2D6 genetic variation on the systemic exposure to medications used by this patient population. Ultimately, the goal of the research is to personalize the use of medications in children by selecting the appropriate dose of the correct medication for individual patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2010-04 |
| Est. Completion | 2015-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01118858
The ClinicalTrials.gov registry entry for NCT01118858 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01118858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01118858 about?
NCT01118858 is a clinical study titled "Biomarkers of CYP2D6 and CYP3A4 Variability in Pediatrics". Cytochrome P450 2D6 (CYP2D6) is an important enzyme in the body for breaking down many medications that are commonly used in children of various ages. The purpose of this proposal is to investigate the relative roles of development and genetic variation in CYP2D6 activity in school-aged children and...
What is the current status of trial NCT01118858?
This trial is currently completed. The enrollment target is 205 participants. The study started on 2010-04. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT01118858?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.